Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies - PubMed (original) (raw)
Review
. 2015 Nov;100(11):4198-207.
doi: 10.1210/jc.2015-2527. Epub 2015 Aug 26.
Affiliations
- PMID: 26308292
- DOI: 10.1210/jc.2015-2527
Review
Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies
Huiping Yuan et al. J Clin Endocrinol Metab. 2015 Nov.
Abstract
Context: An excess circulating uric acid level, even within the normal range, is always comorbid with metabolic syndrome (MS), several of its components, and nonalcoholic fatty liver disease (NAFLD), which was regarded as hepatic manifestation of MS; however, these associations remain controversial.
Objective: This study aimed to quantitatively assess the relationship between the serum uric acid (SUA) levels and the MS/NAFLD risk.
Design: We searched for related prospective cohort studies including SUA as an exposure and MS/NAFLD as a result in MEDLINE (PubMed) and EMBASE databases up to January 31, 2015 and July 28, 2015, respectively. Pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) were extracted. A random-effects model was used to evaluate dose-response relationships.
Main outcomes: On the basis of 11 studies (54 970 participants and 8719 MS cases), a combined RR of 1.72 (95% CI, 1.45-2.03; P < .0001) was observed for the highest SUA level category compared with the lowest SUA level category. Furthermore, based on nine studies (51 249 participants and 8265 MS cases), dose-response analysis suggested that each 1 mg/dL SUA increment was roughly linearly associated with the MS risk (RR, 1.30; 95% CI, 1.22-1.38; P < .0001). Beyond that, SUA level increased NAFLD risk (RR, 1.46; 95% CI, 1.31-1.63). Each 1 mg/dL SUA level increment led to 21% increase in the NAFLD risk.
Conclusions: This meta-analysis suggests that higher SUA levels led to an increased risk of MS regardless of the study characteristics, and were consistent with a linear dose-response relationship. In addition, SUA was also a causal factor for the NAFLD risk.
Similar articles
- Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y. Liu PJ, et al. Climacteric. 2014 Dec;17(6):692-9. doi: 10.3109/13697137.2014.926323. Epub 2014 Aug 7. Climacteric. 2014. PMID: 24884478 - High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Zhou Y, Wei F, Fan Y. Zhou Y, et al. Clin Biochem. 2016 May;49(7-8):636-42. doi: 10.1016/j.clinbiochem.2015.12.010. Epub 2015 Dec 29. Clin Biochem. 2016. PMID: 26738417 Review. - [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
Liu P, Ma F, Lou H, Zhu Y, Chen Y. Liu P, et al. Zhonghua Gan Zang Bing Za Zhi. 2014 Jan;22(1):53-7. doi: 10.3760/cma.j.issn.1007-3418.2014.01.012. Zhonghua Gan Zang Bing Za Zhi. 2014. PMID: 24721245 Chinese. - Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies.
Zhao G, Huang L, Song M, Song Y. Zhao G, et al. Atherosclerosis. 2013 Nov;231(1):61-8. doi: 10.1016/j.atherosclerosis.2013.08.023. Epub 2013 Aug 31. Atherosclerosis. 2013. PMID: 24125412 Review.
Cited by
- Association Between Serum Uric Acid Levels and Metabolic-Associated Fatty Liver Disease in Southeast China: A Cross-Sectional Study.
Ren S, Chen S, Huang J, Yu R, Wu Y, Peng XE. Ren S, et al. Diabetes Metab Syndr Obes. 2024 Sep 7;17:3343-3354. doi: 10.2147/DMSO.S476045. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39268333 Free PMC article. - Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response.
Immanuel S, Kaki A, Jetty RR, Vupputuri SM, K V R, R AS. Immanuel S, et al. Cureus. 2024 Aug 13;16(8):e66784. doi: 10.7759/cureus.66784. eCollection 2024 Aug. Cureus. 2024. PMID: 39268307 Free PMC article. - Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin-a post-hoc analysis of the UTOPIA study.
Katakami N, Mita T, Sato Y, Watada H, Shimomura I. Katakami N, et al. Diabetol Int. 2024 Feb 10;15(3):379-388. doi: 10.1007/s13340-024-00693-x. eCollection 2024 Jul. Diabetol Int. 2024. PMID: 39101158 - Association between physical activity and the prevalence of gout among patients with type 2 diabetes mellitus and hyperuricemia: a two-center population-based cross-sectional study.
Cai N, Chen M, Wu L, Feng P, Ye X, Liu Q, Zhu X, Lu C, Zheng Q, Wang Y. Cai N, et al. Clin Rheumatol. 2024 Sep;43(9):2955-2961. doi: 10.1007/s10067-024-07081-5. Epub 2024 Jul 26. Clin Rheumatol. 2024. PMID: 39060811 Free PMC article. - An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis.
Li Y, Jin-Si-Han EE, Feng C, Zhang W, Wang H, Lian S, Peng J, Pan Z, Li B, Fang Y, Lu Z. Li Y, et al. Int J Clin Oncol. 2024 Sep;29(9):1263-1273. doi: 10.1007/s10147-024-02550-y. Epub 2024 Jun 5. Int J Clin Oncol. 2024. PMID: 38839664
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical